Synlett 2016; 27(15): 2213-2216
DOI: 10.1055/s-0035-1561661
letter
© Georg Thieme Verlag Stuttgart · New York

Organocatalyst-Induced Multicomponent Reaction: An Efficient Procedure for the Activation of Amides

Alireza Samzadeh-Kermani*
Chemistry Department, Faculty of Science, University of Zabol, Zabol, Iran   Email: drsamzadeh@gmail.com
› Author Affiliations
Further Information

Publication History

Received: 06 March 2016

Accepted after revision: 11 May 2016

Publication Date:
09 June 2016 (online)


Abstract

An efficient organocatalytic route for the activation of amide derivatives is reported. In this transformation, amide derivatives were employed as a potential bidentate nucleophile in a reaction involving isoquinoline and propiolates using tetrabutylphosphonium acetate to form 1,2-dihydroisoquinoline skeletons.

Supporting Information

 
  • References and Notes

  • 1 Ramesh P, Reddy NS, Venkateswarlu Y. J. Nat. Prod. 1999; 62: 780
  • 2 Oi S, Ikedou K, Takeuchi K, Ogino M, Banno Y, Tawada H, Yamane T. WO 2002062764 A1, 2002
  • 3 Bentley KW. The Isoquinoline Alkaloids. Vol. 1. Harwood Academic; Australia: 1998
  • 4 Scott JD, Williams RM. Chem. Rev. 2002; 102: 1669
  • 5 Asao N, Yudha SS, Nogami T, Yamamoto Y. Angew. Chem. Int. Ed. 2005; 44: 5526
  • 6 Yanada R, Obika S, Kono H, Takemoto Y. Angew. Chem. Int. Ed. 2006; 45: 3822
  • 7 Shaabani A, Soleimani E, Khavasi HR. Tetrahedron Lett. 2007; 48: 4743
  • 8 Asao N, Iso K, Yudha SS. Org. Lett. 2006; 8: 4149
  • 9 Diaz JL, Miguel M, Lavilla R. J. Org. Chem. 2004; 69: 3550
  • 10 Gao K, Wu J. J. Org. Chem. 2007; 72: 8611
  • 11 Ding Q, Wu J. Org. Lett. 2007; 9: 4959
  • 12 Obika S, Kono H, Yasui Y, Yanada R, Takemoto Y. J. Org. Chem. 2007; 72: 4462
  • 13 Yavari I, Ghazanfarpour-Darjani M, Sabbaghan M, Hossaini Z. Tetrahedron Lett. 2007; 48: 3749
  • 14 Hajinasiri R. Iran J. Org. 2012; 4: 927
  • 15 Nassiri M. Synth. Commun. 2013; 43: 157
  • 17 Typical Procedure for the Preparation of 4 and 6 To a stirred solution of amide (1.5 mmol), propiolate (1.0 mmol), and TBPA (20 mol%) in THF (3 mL), the N-heterocycle (1.0 mmol) was added slowly at 25 °C (for 10 min), and the resulting mixture was stirred at ambient temperature for 12 h. After completion of the reaction (monitored by TLC), the mixture was evaporated in vacuo followed by addition of H2O (10 mL), and the pH was adjusted to 2 using concentrated HCl. Afterwards, CH2Cl2 (5 mL) was added, the mixture was stirred for an additional 30 min, and two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL), the combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo to yield the crude product (purity 75–82%). The crude product was further purified by recrystallization from CH2Cl2–Et2O. Representative Analytical Data Methyl 3-(1-Benzamidoisoquinolin-2(1H)-yl)acrylate (4a) The crude product was purified by recrystallization from CH2Cl2–Et2O affording 0.30 g (89%) of 4a as an orange powder; mp 142–144 °C. IR (KBr): νmax = 1723, 1640, 1546, 1320, 1126 cm–1. 1H NMR (500 MHz, CDCl3): δ = 3.67 (3 H, s, MeO), 5.71 (1 H, d, 3 J = 7.1 Hz, CH), 5.97 (1 H, d, 3 J = 7.6 Hz, CH), 6.69 (1 H, d, 3 J = 7.1 Hz, CH), 6.82 (1 H, d, 3 J = 5.9 Hz, CH), 7.29 (1 H, t, 3 J = 7.0 Hz, CH), 7.29–7.48 (5 H, m, 5 CH), 7.64 (1 H, d, 3 J = 11.4, CH), 7.68–8.80 (3 H, m, 3 CH), 7.89 (1 H, d, 3 J = 5.9, NH). 13C NMR (125.7 MHz, CDCl3): δ = 52.6 (MeO), 66.5 (CH), 93.6 (CH), 104.1 (CH), 125.1 (CH), 125.4 (CH), 125.7 (CH), 125.8 (CH), 126.4 (2 CH), 126.9 (CH), 129.0 (2 CH), 133.1 (CH), 133.6 (C), 134.1 (C), 138.9 (C), 144.1 (C), 165.1 (C), 166.4 (C). MS: m/z (%) = 334 (2) [M+], 320 (12), 276 (25), 172 (37), 105 (56), 77 (100). Anal. Calcd for C20H18N2O3 (334.38): C, 71.84; H, 5.43; N, 8.38. Found: C, 72.08; H, 5.64; N, 8.41. Ethyl 3-(1-Benzamidoisoquinolin-2(1H)-yl)acrylate (4b) The crude product was purified by recrystallization from CH2Cl2–Et2O affording 0.31 g (88%) of 4b as an orange powder; mp 130–133 °C. IR (KBr): νmax = 1726, 1648, 1540, 1337, 1134 cm–1. 1H NMR (500 MHz, CDCl3): δ = 1.26 (3 H, t, 3 J = 6.4 Hz, Me), 4.36 (2 H, q, 3 J = 6.4 Hz, CH2), 5.64 (1 H, d, 3 J = 7.6 Hz, CH), 5.93 (1 H, d, 3 J = 7.0 Hz, CH), 6.67 (1 H, d, 3 J = 7.3 Hz, CH), 6.71 (1 H, d, 3 J = 6.5 Hz, CH), 7.24 (1 H, t, 3 J = 7.1 Hz, CH), 7.27–7.40 (5 H, m, 5 CH), 7.70 (1 H, d, 3 J = 11.6 Hz, CH), 7.68-5.80 (3 H, m, 3 CH), 7.84 (1 H, d, 3 J = 6.5 Hz, NH). 13C NMR (125.7 MHz, CDCl3): δ = 14.9 (Me), 65.7 (CH), 68.7 (CH2), 91.4 (CH), 105.4 (CH), 125.3 (CH), 125.5 (CH), 126.1 (CH), 126.6 (CH), 127.0 (2 CH), 127.4 (CH), 128.7 (2 CH), 132.8 (CH), 132.9 (C), 133.7 (C), 140.1 (C), 143.7 (C), 165.6 (C), 166.9 (C). MS: m/z (%) = 348 (5) [M+], 320 (11), 276 (19), 172 (43), 105 (69), 77 (100). Anal. Calcd for C21H20N2O3 (348.40): C, 72.40; H, 5.79; N, 8.04. Found: C, 72.56; H, 5.93; N, 8.13.